Talazoparib Plus Enzalutamide Delays Disease Progression in HRR-Mutated Metastatic Prostate Cancer

Clinical Oncology News·Apr 8

This story is reported by Clinical Oncology News. Read what other outlets are saying below, then open the original report for full details.